CBG

Cronos Group Reports 2023 Second Quarter Results

Retrieved on: 
Tuesday, August 8, 2023
Capital expenditure, Genetics, Marketing, Patient, Peace, Tax, Cannabinoid, Fleming Companies, Inc, Prescription, Research, CBG, Sale, Fermentation, CBN, Cannabinol, Lemonade, CBC, Investment, SKU, Cannabis, Capital, Depreciation, Growth, Bookkeeping, Drug, Pharmaceutical industry, Cronos

TORONTO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2023 second quarter business results.

Key Points: 
  • Furthermore, the weakened Canadian dollar and Israeli shekel against the U.S. dollar during the current period adversely impacted results.
  • Cronos expects to continue to operate the Cronos Fermentation facility with a phased reduction and planned exit by the end of 2023.
  • Cronos Growing Company Inc. (“Cronos GrowCo”) reported to the Company preliminary unaudited net revenue to licensed producers, excluding sales to the Company, of approximately $3.6 million in the second quarter of 2023.
  • ET to discuss 2023 Second Quarter business results.

New Venture Group of Companies Announces the Commercialization of its Proprietary Customizable Bio-communication Software Programs

Retrieved on: 
Thursday, August 3, 2023
CBDA, FAAH, Cannabinoid, Monoacylglycerol lipase, THCA, Acupuncture, Mineral, CSE, Canadian Securities Exchange, AEA, Marketing, Enzyme, AB, Woman, Software, Research, Equity, CBG, Terpene, Science, Vitamin D, Vitamin, CBC, Investment, MAGL, Offering, Blood, CBD, Vitamin C, Cannabis, Ageing, Health, THC, Biomass, Iron, Medicinal plants, Fine chemical, Dietary supplement, Calcium

EDMONTON, AB, Aug. 3, 2023 /PRNewswire/ - New Venture Group of Companies (the "Company") is pleased to announce today the launch of its proprietary customizable bio-communication software programs (the "Software") for commercial use in the botanical, cannabis, medical and natural health/nutraceutical sectors.

Key Points: 
  • EDMONTON, AB, Aug. 3, 2023 /PRNewswire/ - New Venture Group of Companies (the "Company") is pleased to announce today the launch of its proprietary customizable bio-communication software programs (the "Software") for commercial use in the botanical, cannabis, medical and natural health/nutraceutical sectors.
  • The Software can also be customized for treatment protocols for specific natural health modalities (eg.
  • The Software produces individualized reports that tests for actual and optimal levels of thirty essential vitamins and minerals.
  • We are now offering medical cannabis consultations using our proprietary customizable bio-communication software.

MariMed Reports Second Quarter 2023 Earnings

Retrieved on: 
Wednesday, August 2, 2023
Boston, Capital expenditure, IRS, Overalls, Immunity, GAAP, CBG, Relaxation, Forecasting, EBITDA, Castle of Castro Marim, SEDAR, Capital, Adjustment, THC, Environment, Boston Tea Party, Bank, Cryptocurrency, Hospital, Nightclub, Asset management

“Our 11% year-over-year revenue growth this past quarter demonstrated strong execution during a continued challenging environment,” said Susan Villare, Chief Financial Officer.

Key Points: 
  • “Our 11% year-over-year revenue growth this past quarter demonstrated strong execution during a continued challenging environment,” said Susan Villare, Chief Financial Officer.
  • The conference call may be accessed through MariMed’s Investor Relations website, or by clicking the following link: MRMD Q223 Earnings Webcast .
  • During the second quarter, the Company announced the following developments in the implementation of its strategic growth plan:
    April 4: The Maryland Medical Cannabis Commission issued approval to once again manufacture and sell high-dose edibles.
  • Subsequent to the end of the second quarter, the Company announced the following development:
    July 13: MariMed Stages the ‘Boston 280E THC Party’ in Boston Harbor To Protest Unfair Cannabis Industry Tax Laws.

Cerus Corporation Announces Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 2, 2023
Biotechnology, Medical Devices, Other Health, Health, Health Technology, SG, U.S. Department of Defense Strategy for Operating in Cyberspace, Defense, Research, CBG, Government, MDR, EBITDA, PMA, Corporation, Patient, Investment, CERS, Red blood cell, Growth, R, Adjustment, FDA, Hand, Cryptocurrency, Pharmaceutical industry, Video game, Bank, EU, Green Man, Cerus Corporation

Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023.
  • Selling, general, and administrative (SG&A) expenses for the second quarter of 2023 totaled $20.5 million, compared to $19.5 million for the second quarter of 2022.
  • R&D expenses for the second quarter of 2023 were $19.2 million, compared to $15.2 million for the second quarter of 2022.
  • Net loss attributable to Cerus Corporation for the second quarter of 2023 was $13.3 million, or $0.07 per basic and diluted share, compared to a net loss attributable to Cerus Corporation of $8.4 million, or $0.05 per basic and diluted share, for the second quarter of 2022.

Hemp, Inc. Reports: Hemp Seed and Hemp Fiber Set to Flourish on a Global Scale

Retrieved on: 
Thursday, July 27, 2023
CBDA, Seed, Anxiety, Cannabinoid, Absorption, CBG, Certification, CBN, Biodiversity, Hemp, Soil, Restaurant, OTC, MCT, Cannabis, Coffee, FashionUnited, Health, Relaxation, CBGA, News, Agriculture, CBD

According to the analysis, the global hemp seed market's rapid expansion is attributed to two key driving forces.

Key Points: 
  • According to the analysis, the global hemp seed market's rapid expansion is attributed to two key driving forces.
  • Hemp seeds, known for their nutritional value and versatility, have gained popularity as a powerhouse ingredient in a variety of plant-based food products.
  • Moreover, the report's recommendation for establishing hemp fiber standards provides Hemp, Inc. with an opportunity to contribute to industry-wide best practices and set the bar for responsible hemp cultivation.
  • By avoiding hazardous pesticides and seeking organic and regenerative certifications, Hemp, Inc. can demonstrate its commitment to producing high-quality, environmentally friendly hemp fiber products.

Hemp, Inc. Reports: Hemp-Based Product Sales Expected to Reach $16.2 Billion by 2033

Retrieved on: 
Thursday, July 20, 2023
CBDA, Food, Seed, Pharmacy, Anxiety, Hemp juice, Cannabinoid, Absorption, CBG, Sale, CBN, Restaurant, OTC, MCT, Cannabis, Coffee, Paper, Growth, Relaxation, Textile, CBGA, News, Hemp, CBD

The report highlights segments and sub-segments within the hemp industry and analyzes each in terms of value and volume.

Key Points: 
  • The report highlights segments and sub-segments within the hemp industry and analyzes each in terms of value and volume.
  • It also “elaborates market behavior of each vendor operating in the hemp-based products market”.
  • The Company also discovered its grounded kenaf hemp blend makes the perfect substrate to grow healthy and/or medicinal mushrooms.
  • The Company’s CBD, CBDA, CBG, CBGA, and CBN product lines are highly potent therapeutic doses that have received rave reviews.

Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay

Retrieved on: 
Monday, July 17, 2023
Aureus, CBD, TSX, FSE, Cannabigerol, CBG, Rare-earth element, Fine chemical, Cannabidiol

TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce that through its majority owned subsididery Santa Marta Golden Hemp the Company has completed the commercial export of aureus branded products into Paraguay.

Key Points: 
  • TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce that through its majority owned subsididery Santa Marta Golden Hemp the Company has completed the commercial export of aureus branded products into Paraguay.
  • The commercial export included Aureus branded purified Cannabidiol (CBD) and Cannabigerol (CBG) which is a part of the company’s portfolio of cannabinoid active pharmaceutical ingredients).
  • This transaction also marks the 17th international market for Aureus branded products and 20th market for all Avicanna products which further demonstrates the company’s capabilities in navigating complex regulatory processes for its commercialization efforts internationally.

Organigram Reports Third Quarter Fiscal 2023 Results

Retrieved on: 
Friday, July 14, 2023
Cannabis, Natural Resources, Purchasing, THCV, Holy Mountain, Drink, Aerosol, Seed, Genetics, Biolab, Ontario Cannabis Retail Corporation, Cannabinoid, Emulsion, Research, WHC, CBG, Public expenditure, PDC, Data, Investment, Power purchase agreement, CBD, Milk, R, THC, Fiscal, Drug, Tea, Fine chemical, Pharmaceutical industry, Phylo (video game), Organizational chart

Q3 Fiscal 2023 saw the introduction of a record-breaking 28 new SKUs to the market for Organigram.

Key Points: 
  • Q3 Fiscal 2023 saw the introduction of a record-breaking 28 new SKUs to the market for Organigram.
  • Organigram has introduced one of its newest high THC cultivars, Tropical Reign, in large format 28g bags, under its Holy Mountain brand.
  • For Fiscal 2023 the Company had approximately $10 million in remaining capex committed to the three facilities.
  • Organigram believes its capital position is healthy and that there is sufficient liquidity available for the near to medium term.

Global Cannabis Market Report 2023 Uncovers Medicinal Uses, Market Trends, and Types of Cannabis - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 13, 2023
Alternative Medicine, Health, Natural Resources, Cannabis, CBD, CBN, THC, Table, CBC, Strategic planning, CBG, Drug

The comprehensive report provides researchers, analysts, and industry professionals with a wealth of information on cannabis.

Key Points: 
  • The comprehensive report provides researchers, analysts, and industry professionals with a wealth of information on cannabis.
  • It explores the components of cannabis, including THC, CBD, CBN, CBG, and CBC, highlighting their unique properties and potential benefits.
  • The report also delves into the different types of cannabis and their characteristics, effects, and applications.
  • It examines the effects of cannabis on the human body and its medicinal use for various conditions.

Hemp, Inc. Reports: Hemp Recognized as Specialty Crop with US Department of Agriculture

Retrieved on: 
Tuesday, July 11, 2023
CBDA, Food, U.S. Department of Agriculture Cotton Annex, ATAC, Anxiety, Tobacco, Policy, Cannabinoid, USTR, Federal, Absorption, ATACS, CBG, CBN, Restaurant, OTC, MCT, Cannabis, Coffee, Relaxation, CBGA, News, Trade, Rope, Dietary supplement, Hemp, CBD, Agriculture

In a bold, significant move, the U.S. Department of Agriculture’s Foreign Agriculture Service, retitled one of its Agricultural Technical Advisory Committees (ATACs) to include “hemp”.

Key Points: 
  • In a bold, significant move, the U.S. Department of Agriculture’s Foreign Agriculture Service, retitled one of its Agricultural Technical Advisory Committees (ATACs) to include “hemp”.
  • The new ATAC name that incorporates hemp is Tobacco, Cotton, Peanuts, and Hemp.
  • Hemp, Inc. is one of the pioneers in the hemp industry, and its foothold runs 14 years deep.
  • Hemp, Inc. also discovered its grounded kenaf hemp blend makes the perfect substrate to grow healthy and/or medicinal mushrooms.